ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,963.99
      -1.22%
      US Tech 100
      20,876.80
      -1.45%
      Dow Jones
      42,985.89
      -0.78%
      Brent Oil
      73.895
      1.38%
      Bitcoin
      94,132.97
      -1.62%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV

      6. Essa Pharma Inc (EPI) Quote

      Essa Pharma Inc

      Essa Pharma Inc (EPI)

      WisdomTree India Earnings Fund
      8.20
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      8.20
      Bid
      6.50
      Ask
      8.95
      Volume
      -
      0.00 Day's Range 0.00
      8.20 52 Week Range 8.20
      Market Cap
      361.62M
      Previous Close
      8.20
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      44,100,000
      Dividend Yield
      -
      PE Ratio
      -2.77
      Earnings Per Share (EPS)
      -0.6
      Revenue
      -
      Net Profit
      -26.58M

      About Essa Pharma Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.essapharma.com
      Headquarters
      Vancouver, British Columbia, Can
      Founded
      -
      Essa Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker EPI. The last closing price for Essa Pharma was $8.20. Over the last year, Essa Pharma shares have traded in a share price range of $ 8.20 to $ 8.20.

      Essa Pharma currently has 44,100,000 shares outstanding. The market capitalization of Essa Pharma is $361.62 million. Essa Pharma has a price to earnings ratio (PE ratio) of -2.77.

      Ask ADVFN Intelligence (AI)

      EPI Latest News

      More News

      ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

      ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders Canada NewsWire HOUSTON and VANCOUVER, BC, Feb. 25, 2021 HOUSTON and VANCOUVER, BC, Feb. 25, 2021 /CNW/...

      February 25 2021
      PR Newswire (Canada)

      ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

      ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER...

      January 13 2021
      PR Newswire (Canada)

      ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

      ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 Canada NewsWire VANCOUVER and HOUSTON, Dec. 15, 2020 VANCOUVER and...

      December 15 2020
      PR Newswire (Canada)

      ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

      ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference Canada NewsWire HOUSTON and VANCOUVER, BC, Nov. 25, 2020 HOUSTON and VANCOUVER, BC, Nov. 25, 2020 /CNW/ - ESSA Pharma...

      November 25 2020
      PR Newswire (Canada)

      ESSA Pharma Inc. Announces Delisting from the TSX-V

      ESSA Pharma Inc. Announces Delisting from the TSX-V Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 26, 2020 HOUSTON and VANCOUVER, BC, Oct. 26, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA" or...

      October 26 2020
      PR Newswire (Canada)

      ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

      ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 24, 2020 HOUSTON and VANCOUVER, BC, Oct. 24, 2020 /CNW/...

      October 24 2020
      PR Newswire (Canada)

      ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

      ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia Canada NewsWire HOUSTON, Texas and VANCOUVER, BC, Oct. 19, 2020 HOUSTON, Texas and...

      October 19 2020
      PR Newswire (Canada)

      ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

      ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 21, 2020 HOUSTON and VANCOUVER, BC, Sept. 21, 2020...

      September 21 2020
      PR Newswire (Canada)

      ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

      ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020 Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 17, 2020 HOUSTON and...

      September 17 2020
      PR Newswire (Canada)

      ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

      ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER, BC, Sept...

      September 14 2020
      PR Newswire (Canada)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1008.28.28.200CS
      4008.28.28.200CS
      12008.28.28.200CS
      26008.28.28.200CS
      52008.28.28.200CS
      156008.28.28.200CS
      2601.217.1428571429711.3445358.83179165CS

      EPI - Frequently Asked Questions (FAQ)

      What is the current Essa Pharma share price?
      The current share price of Essa Pharma is $ 8.20
      How many Essa Pharma shares are in issue?
      Essa Pharma has 44,100,000 shares in issue
      What is the market cap of Essa Pharma?
      The market capitalisation of Essa Pharma is CAD 361.62M
      What is the 1 year trading range for Essa Pharma share price?
      Essa Pharma has traded in the range of $ 8.20 to $ 8.20 during the past year
      What is the PE ratio of Essa Pharma?
      The price to earnings ratio of Essa Pharma is -2.77
      What is the reporting currency for Essa Pharma?
      Essa Pharma reports financial results in USD
      What is the latest annual profit for Essa Pharma?
      The latest annual profit of Essa Pharma is USD -26.58M
      What is the registered address of Essa Pharma?
      The registered address for Essa Pharma is SUITE 3500, THE STACK, 1133 MELVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6E 4E5
      What is the Essa Pharma website address?
      The website address for Essa Pharma is www.essapharma.com
      Which industry sector does Essa Pharma operate in?
      Essa Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ADG.HArcus Development Group Inc
      $ 0.015
      (200.00%)
      		2k
      BYM.HBaymount Incorporated
      $ 0.015
      (200.00%)
      		293.75k
      CCZ.PChablis Capital Corp
      $ 0.12
      (100.00%)
      		1,000
      CANSWildpack Beverage Inc
      $ 0.01
      (100.00%)
      		145.4k
      QNCQuantum Emotion Corp
      $ 0.99
      (86.79%)
      		3.11M
      CPLCopper Lake Resources Ltd
      $ 0.005
      (-50.00%)
      		90k
      TVC.HThree Valley Copper Corp
      $ 0.005
      (-50.00%)
      		15.3k
      NICKNickelex Resource Corporation
      $ 0.005
      (-50.00%)
      		10k
      TVITVI Pacific Inc
      $ 0.005
      (-50.00%)
      		100.05k
      CMILCapella Minerals Ltd
      $ 0.035
      (-41.67%)
      		112.55k
      DMDataMetrex AI Limited
      $ 0.005
      (0.00%)
      		5.31M
      GPUSAlset AI Ventures Inc
      $ 0.135
      (22.73%)
      		3.49M
      QNCQuantum Emotion Corp
      $ 0.99
      (86.79%)
      		3.11M
      MATEBlockmate Ventures Inc
      $ 0.29
      (38.10%)
      		2.85M
      ONE01 Communique Laboratory Inc
      $ 0.425
      (57.41%)
      		1.99M

      Discussion

      View Full Feed
      marcis marcis 5 minutes ago
      Your statement is 100% not true and misleading
      The management put out a statement no R/S

      Why late comers and flippers who sold think RDAR value is too much for cheapo traders
      Posts 2021 style trading

      Yeah we get it

      NeXT impending doom a
      RDAR
      lovethatgreen lovethatgreen 5 minutes ago
      Longtime no see
      TORVF
      waterchaser waterchaser 5 minutes ago
      Ask Tony if he's dumping and get back to us.
      USEI
      janice shell janice shell 6 minutes ago
      That makes sense.
      Myth Myth 6 minutes ago
      Storyville - Good Day For The Blues live

      https://www.youtube.com/watch?v=Wu3vkHwxEaE
      Trooperstocks Trooperstocks 6 minutes ago
      $RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html
      RELT
      tothe tothe 6 minutes ago
      GDVM chart says we are in the right place. Close to crossing MA(50) since last September, MACD in reset, bear PSAR near possible flip to cover and Swing Traders may notice our exhaustion gap up.
      ~~ It is about time the TREND and MOMO indicators start backing up VOLUME MONEY that has been scr
      GDVM
      Trooperstocks Trooperstocks 6 minutes ago
      $RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html
      RELT
      attilathehunt attilathehunt 6 minutes ago
      I agree!!


      I am very positive on a positive outcome for L.

      Being prepared for numerous outcomes is a shrewd decision.


      Something to think about....

      Here are some companies that might face increased competition if DCVax-L rec
      NWBO
      dexprs dexprs 6 minutes ago
      A few more greens than reds now, but today still cannot be mistaken for a rally..
      m$teamworkotc m$teamworkotc 6 minutes ago
      like I said for years----the MMS indeed control stocks in these pink sewers....it will run when they are heavily LOADED
      HMBL
      dirkv dirkv 6 minutes ago
      HIGH RISK!!!
      Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
      I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

      Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh
      MTNB
      rbb rbb 6 minutes ago
      🤣 ...55/.56 break going to be big!
      BURU
      RMS555 RMS555 6 minutes ago
      New Year will just bring more DILUTION according to your overview! Add more dilution next year on top of the 3.9 BILLION Shares diluted since September!

      PSRU IS A SCAM , YOU KNOW THIS..... Xavier Mitchell, and YOU, are WANNABE's!!!!


      .
      PSRU
      dirkv dirkv 7 minutes ago
      HIGH RISK!!!
      Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
      I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

      Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh
      MTNB
      WinstonCup WinstonCup 7 minutes ago
      Yes, we now know that MjLink buy in was just a scam that Ken ran.
      WDLF
      Trooperstocks Trooperstocks 7 minutes ago
      $HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd
      HNOI
      Trooperstocks Trooperstocks 7 minutes ago
      $HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd
      HNOI
      Trooperstocks Trooperstocks 7 minutes ago
      $ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html
      ACGX
      Trooperstocks Trooperstocks 7 minutes ago
      $ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html
      ACGX
      iclight iclight 7 minutes ago
      The goalpost of buying/selling a stock is to make money unless you are an idiot.
      NWBO
      Fallingknife75 Fallingknife75 7 minutes ago
      Reading is fun.

      https://www.otcmarkets.com/stock/RDAR/news/Raadr-Inc-Announces-Agreement-with-Shareholders-for-the-Cancellation-of-17-Billion-Common-Shares-and-Affirms-No-Reverse-?id=456191

      Knife
      RDAR
      biotechinvestor1 biotechinvestor1 7 minutes ago
      Bristol-Myers: FDA approves nivolumab and hyaluronidase-nhy for subcutaneous injection
      11:32 AM ET 12/27/2024 | Briefing.com
      BMY
      "On December 27, 2024, the Food and Drug Administration approved nivolumab and hyaluronidase-nhy (Opdivo Quantig, Bristol
      Myers Squibb Company)
      BMY
      inventor1 inventor1 7 minutes ago
      Please tell me you were looking in the mirror when you made that statement 💯🤣
      HMBL

      Your Recent History

      TSXV
      EPI
      Essa Pharma
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads